 |
|
|
| |
Long-term Entecavir Treatment for Up to 5 Years in Asians With HBeAg-positive Chronic Hepatitis B: Results From ETV-022 and -901
|
| |
| |
Reported by Jules Levin
AASLD Nov 2 2010 Boston
Calvin Pan1, Myron Tong2, Kris Kowdley3, Ke-Qin Hu4, Ting-Tsung Chang5, Ching-Lung Lai6, Seung Kew Yoon7, Samuel S Lee8, David Cohen9, Hong Tang10, Naoky Tsai11
1. Division of Gastroenterology, Mount Sinai School of Medicine, New York, USA; 2. Pfleger Liver Institute, University of California School of Medicine, Los Angeles, USA; 3. Center for Liver Disease, Virginia Mason Medical Center, Seattle, USA; 4. Division of Gastroenterology, University of California, Irvine Medical Center, Orange, USA; 5. National Cheng Kung University Medical College, Tainan, Taiwan;
6. Queen Mary Hospital, Hong Kong, China; 7. Seoul St. Mary's Hospital, Catholic University Medical College, Seoul, Korea; 8. Foothills Provincial General Hospital, University of Calgary, Calgary, Canada; 9. Research & Development, Bristol-Myers Squibb Company, Wallingford, USA; 10. Research & Development, Bristol-Myers Squibb Company, Plainsboro, USA; 11. University of Hawaii, Honolulu, USA
|
| |
|
|
|
|
|
